A phase i clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer

Nobuaki Suzuki, Shoichi Hazama, Tomio Ueno, Hiroto Matsui, Yoshitaro Shindo, Michihisa Iida, Kiyoshi Yoshimura, Shigefumi Yoshino, Kazuyoshi Takeda, Masaaki Oka

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'A phase i clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences